










































Runx1 is required for progression of CD41+ embryonic
precursors into HSCs but not prior to this
Citation for published version:
Liakhovitskaia, A, Rybtsov, S, Smith, T, Batsivari, A, Rybtsova, N, Rode, C, de Bruijn, M, Buchholz, F,
Gordon-Keylock, S, Zhao, S & Medvinsky, A 2014, 'Runx1 is required for progression of CD41+ embryonic
precursors into HSCs but not prior to this' Development, vol. 141, no. 17, pp. 3319-3323. DOI:
10.1242/dev.110841
Digital Object Identifier (DOI):
10.1242/dev.110841
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:




This is an Open Access article distributed under the terms of the Creative Commons Attribution
License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution and reproduction in any medium provided that the original work is properly attributed.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
RESEARCH REPORT STEM CELLS AND REGENERATION
Runx1 is required for progression of CD41+ embryonic precursors
into HSCs but not prior to this
Anna Liakhovitskaia1, Stanislav Rybtsov1, Tom Smith1, Antoniana Batsivari1, Natalia Rybtsova1,
Christina Rode2, Marella de Bruijn2, Frank Buchholz3, Sabrina Gordon-Keylock1, Suling Zhao1
and Alexander Medvinsky1,*
ABSTRACT
Haematopoiesis in adult animals is maintained by haematopoietic
stem cells (HSCs), which self-renew and can give rise to all blood cell
lineages. TheAGM region is an important intra-embryonic site of HSC
development and a wealth of evidence indicates that HSCs emerge
from the endothelium of the embryonic dorsal aorta and extra-
embryonic large arteries. This, however, is a stepwise process that
occurs through sequential upregulation of CD41 and CD45 followed
by emergence of fully functional definitive HSCs. Although largely
dispensable at later stages, the Runx1 transcription factor is crucially
important during developmental maturation of HSCs; however,
exact points of crucial involvement of Runx1 in this multi-step
developmental maturation process remain unclear. Here, we have
investigated requirements for Runx1 using a conditional reversible
knockout strategy.We report that Runx1 deficiency does not preclude
formation of VE-cad+CD45−CD41+ cells, which are phenotypically
equivalent to precursors of definitive HSCs (pre-HSC Type I) but
blocks transition to the subsequent CD45+ stage (pre-HSC Type II).
These data emphasise that developmental progression of HSCs
during a very short period of time is regulated by precise
stage-specific molecular mechanisms.
KEY WORDS: AGM region, CD41, HSC, Runx1, Mouse
INTRODUCTION
Embryonic development of the haematopoietic stem cell lineage
occurs through sequential maturation stages (Cumano and Godin,
2007; Dzierzak and Speck, 2008; Medvinsky et al., 2011). By
mid-gestation, definitive HSCs (dHSCs) emerge in the aorta-gonad-
mesonephros (AGM) region, as well as in placenta, large extra-
embryonic vessels, yolk sac and perhaps head (de Bruijn et al., 2000;
Dzierzak and Robin, 2010; Gekas et al., 2005; Gordon-Keylock
et al., 2013; Li et al., 2012; Medvinsky and Dzierzak, 1996). The
current prevailing view that HSCs originate in the dorsal aorta is
supported by strong evidence in lower vertebrates, mouse and
human (Bertrand et al., 2010, 2005; Ciau-Uitz et al., 2000;
Dieterlen-Lievre, 1975; Ivanovs et al., 2011; Kissa and Herbomel,
2010; Medvinsky and Dzierzak, 1996; Medvinsky et al., 1993;
Swiers et al., 2013; Taoudi and Medvinsky, 2007). Definitive
HSCs (dHSC) originate from the mesoderm that generates the VE-
cadherin+ endothelium, part of which becomes haematogenic and in
turn generates the haematopoietic compartment marked by CD41
and subsequently by CD45 (Cumano and Godin, 2007; Dzierzak
and Speck, 2008; Medvinsky et al., 2011; Mikkola et al., 2003;
Rybtsov et al., 2011; Taoudi et al., 2008). Runx1 is a transcription
factor playing a key role in development of the haematopoietic
system; however, it is largely dispensable for the maintenance of
adult bone marrow HSCs (Ichikawa et al., 2004; North et al., 1999;
Okuda et al., 1996; Putz et al., 2006; Wang et al., 1996). Germline
Runx1 homozygous deletion blocks both erythro-myeloid
haematopoietic progenitors (CFU-C) and HSC formation (Cai
et al., 2000), which leads to severe anaemia and embryonic death by
E12.5. Conditional genetic and cell fate analysis usingVE-cadherin-
Cre deletor mice indicates that Runx1 is crucial for the endothelial-
haematopoietic transition during HSC formation (Chen et al., 2009).
However, this transition involves at least three sequential stages of
maturation marked by continuous expression of VE-cadherin and
sequential upregulation of haematopoietic markers, first CD41 (pre-
HSC Type I: VE-cad+CD41+CD45−) and subsequently CD45
(pre-HSC Type II: VE-cad+CD45+), before they become fully
functional definitive HSCs (Rybtsov et al., 2011; Taoudi et al.,
2008). Time specific-induced inactivation shows that Runx1 is
critically important for HSC development even at E11.5 (Tober
et al., 2013). This raises the question of exactly when HSC
development in Runx1 null embryos is blocked. Here, using Runx1
conditional reversible knockouts (Liakhovitskaia et al., 2009;
Samokhvalov et al., 2006), we show that contrary to previously
held opinion, the HSC lineage inRunx1 knockout embryos develops
up to the point when it expresses CD41, considered to be a
haematopoietic commitment marker in development (Ferkowicz
et al., 2003; Mikkola et al., 2003; Mitjavila-Garcia et al., 2002).
Although the CD41+ cell population is smaller in knockout
embryos, it is clearly detectable and is less apoptotic than
haematopoietic cells in wild-type embryos. Accordingly,
conditional restoration of the Runx1 locus using CD41-Cre deletor
mice rescues definitive HSCs (for experimental design, see
supplementary material Fig. S1A). In summary, we show that in
the complete absence of Runx1, haematopoietic specification of the
HSC lineage in the embryo is initiated towards the CD41+ stage, but
cannot progress.
RESULTS AND DISCUSSION
We investigated whether Runx1-deficient embryos show any
haematopoietic commitment beyond primitive erythropoiesis
(Okuda et al., 1996) and detected by RT-PCR an early
haematopoietic marker, CD41, in E11.5 Runx1 knockout embryos
(Fig. 1A). Flow cytometry analysis confirmed the presence of a lowReceived 1 April 2014; Accepted 9 July 2014
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CD41-expressing (CD41lo) cell population and very few bright
CD41-expressing (CD41hi) cells in Runx1 knockout embryos
compared with heterozygous littermate controls (Fig. 1B;
supplementary material Fig. S2A). CD41lo cells in Runx1
knockout embryos could be identified in the area of the dorsal
aorta using immunofluorescence (Fig. 1C). By contrast, the CD45+
population is practically non-detectable (Fig. 1A,B). We found that
in Runx1 heterozygous and wild-type embryos, a large proportion of
both CD41+ and CD45+ haematopoietic cells were apoptotic, as
evidenced by annexin V staining (Fig. 2A; supplementary material
Fig. S2A; data not shown) and active caspase 3 staining of many
cells in intra-aortic clusters (Fig. 2B). In individual embryos,
25-55% of intra-aortic clusters contained at least one active caspase
3+ cell, and some clusters were entirely apoptotic (supplementary
material Fig. S2B). In layers surrounding the dorsal aorta, 31-47%
of CD45+ cells were apoptotic (supplementary material Fig. S2B).
However, the CD41lo population in Runx1 knockout embryos was
less apoptotic than in littermate controls (Fig. 2A). A similar
tendency was observed in CD41hi cells, which were produced in
considerably smaller numbers in Runx1 knockout embryos
(Fig. 2A). Flow cytometry analysis has shown that phenotypic
equivalents of pre-HSC Type I (VE-cad+CD45−CD41lo) can be
detected in Runx1 mutants (Fig. 1B, middle panel). We therefore
investigated whether the block in HSC development occurs in the
CD41 compartment and can be overcome by restoration of Runx1
expression in CD41+ cells. To this end, [CD41-Cre :: Runx1LacZ/Δ]
embryos were generated in which both Runx1 alleles are non-
functional, of which one is stably deleted (Runx1Δ) and the other
(Runx1LacZ) can be reactivated through Cre-mediated recombination,
hereafter referred to as Runx1Re (see Materials and Methods;
supplementary material Fig. S1) (Samokhvalov et al., 2006). In
contrast to Runx1LacZ/Δ knockout embryos, Runx1Re/Δ embryos
showed clear signs of rescued haematopoiesis. Both the E10.5 AGM
region and the yolk sac developed CD41hi cells similar to Runx1
heterozygous littermates (Fig. 1B and data not shown). CD45+
populations were also observed in the AGM region and yolk sac of
rescued embryos (Fig. 1B and data not shown). In contrast to Runx1
mutants, Runx1Re/Δ embryos were no longer dying by E12.5 and
survived until birth, but as expectedwere not found alive after that due
to other non-haematopoietic defects (Liakhovitskaia et al., 2010).
To testwhether development ofHSCswas rescued, foetal liver cells
from E14.5 Runx1Re/Δ embryos were transplanted into irradiated
recipients. This led to successful long-term multi-lineage donor-
derived engraftment, with only one exception (Fig. 3B). All donor-
derived lymphoid and myeloid lineages were represented similar to
control Runx1 heterozygous transplants (Fig. 3E). Transplantations
into secondary recipients also gave multi-lineage donor-derived
haematopoietic engraftment (data not shown). However, when we
testedwhetherHSCs are rescued in theAGM region, we found that, in
contrast to Runx1 heterozygous AGM regions, transplantation of
E11.5 Runx1Re/Δ AGM regions did not produce haematopoietic
repopulation (Fig. 3C). One out of five yolk sacs and one of six
placentas were able to repopulate irradiated recipients (not shown). To
test the possibility of delayed HSC development in rescued embryos,
AGM region explants were cultured for 4 days in conditions
supporting HSC development followed by transplantation into
irradiated recipients (Fig. 3D). All four recipients transplanted
showed high levels of donor-derived multi-lineage haematopoietic
engraftment, thus demonstrating the presence of rescued pre-HSCs in
the AGM region of Runx1Re/Δ embryos (Fig. 3D). None of the five
Runx1LacZ/ΔAGMexplants, which did not harbour the Cre transgene,
were able to repopulate recipient mice.
In previous reports, inactivation ofRunx1 in theVE-cad+population
suggested that Runx1 is essential for endothelio-haematopoietic
transition but not subsequently, when CFU-Cs and HSCs start
expressing Vav (Chen et al., 2009). However, continuous expression
of VE-cadherin over several HSC developmental stages within the
Fig. 1.Runx1 knockout embryos developCD41+ cells. (A) CD41 (left panel)
and CD45 (right panel) mRNA are detected in wild-type and Runx1
knockout embryos by RT-PCR. E9.5 Runx1 knockout body and yolk sac (YS)
(lanes 1 and 2, respectively); E9.5 wild-type body and YS (lanes 3 and 4,
respectively); E11.5 Runx1 knockout and wild-type YS (lanes 5 and 6,
respectively); H20 control (lane 7). (B) Flow cytometry analysis of Runx1
heterozygous, Runx1 knockout [Runx1LacZ/Δ] and rescued [CD41-Cre::
Runx1LacZ/Δ] embryos (E10.5 AGM regions) obtained through crossing as
outlined in supplementary material Fig. S1. (Top row) Runx1wt/Δ and rescued
Runx1Re/Δ embryos contain both CD41lo and CD41hi cells; however, knockout
Runx1LacZ/Δ embryos develop mainly CD41lo cells (7AAD+Ter119+ cells are
excluded). (Middle row) Runx1LacZ/Δ embryos contain VEcad+CD45−CD41lo
cells bearing the pre-HSCs Type I phenotype (7AAD+Ter119+VE-cad- cells
are excluded). (Bottom row) CD45+ cells are absent in Runx1 knockout
embryos but are rescued in [CD41-Cre::Runx1lLacZ/Δ] embryos (7AAD+Ter119+
cells are excluded). (C) CD41+ and CD31+ cells in the E10.5 dorsal aorta of
wild-type andRunx1LacZ/Δ knockout embryos (confocalmicroscopy). Scale bars:
50 µm.
3320











VE-cad/Vav expression time window obscures the exact initial point
at which Runx1 deficiency blocks this process. Our data demonstrate
that, in Runx1 knockout embryos, initial haematopoietic specification
does occur. Indeed, while Runx1LacZ/Δ knockout embryos developVE-
cad+CD41lowCD45− cells, low numbers of CD45+ cells are generated
at E9.5 but disappear by E11.5. However, CD41low cells in Runx1 null
embryos are stably present and are less apoptotic than in control Runx1
heterozygous embryos. This explains why successful restoration of
theRunx1 functional allele in theCD41+ population ofmutant embryos
rescued both CFU-Cs and definitive HSCs. Therefore, in vivoRunx1 is
required for transition of CD41+ cells into the CD45+ cells but not prior
to that. This result contradicts previous reports indicating that Runx1
deficiency blocks transition from CD41-negative endothelial into
CD41+haematopoietic cells (Bertrandet al., 2008;Lancrin et al., 2009).
This discrepancy could bedue to the use of anEScell systemas amodel
system in which haematopoietic differentiation may deviate from the
in vivo development, or due to differences in sensitivity of methods of
CD41detection.However, an early study reported that Runx1-deficient
ES cells can generate CD41+ cells lacking Kit expression (Mikkola
et al., 2003).Of note, someRunx1-deficient zebrafish do recover froma
larval ‘bloodless’ phase and develop to fertile adults with multilineage
haematopoiesis (Sood et al., 2010), which might be explained at least
partly by initiation of the haematopoietic programme in the absence of
Runx1. It would be interesting to investigate whether Runx1-deficient
cells in zebrafish, which die attempting to undergo endothelial-
haematopoietic transition in the dorsal aorta, acquire the CD41+
phenotype prior to that (Kissa and Herbomel, 2010). Apoptosis
observed during normal early haematopoietic development is an
interesting phenomenon. Significant reduction of apoptosis in
haematopoietic cells of Runx1-deficient embryos concurrent with
blockade of haematopoietic differentiation suggests that apoptosis is an
attribute of haematopoietic differentiation and not of themost immature
CD41 fraction.
In summary,we demonstrate that, in the absence ofRunx1, theHSC
lineage progresses to theCD41+ stage but ceases further development.
Therefore, transition from the CD41− endothelium into the
haematopoietically committed CD41+ stage is Runx1 independent.
This studyprovides a better understandingofRunx1-dependent check-
points duringHSCdevelopment,whichmaybe required for generating
definitive HSCs from pluripotent ES/iPS cells in vitro.
MATERIALS AND METHODS
Mice
All mice used to generate embryos were bred to the C57BL/6 (CD45.2/2)
background. Transgenic mice used in this study have been described
previously: CD41-Cre deletor mice (Emambokus and Frampton, 2003;
Rybtsov et al., 2011); activatable Runx1LacZ/wt mice (Samokhvalov
et al., 2006); and conditional Runx1fl/fl knockout mice (Putz et al., 2006).
Runx1fl/wt mice were used to generate Runx1Δ/wt by Cre-mediated excision.
For experimental crossings, we always used [CD41-Cre :: Runx1Δ/wt]
males and Runx1LacZ/wt females (supplementary material Fig. S1). The
morning of discovery of the vaginal plug was designated embryonic day 0.5.
[CD41-Cre :: Runx1Δ/LacZ] embryos in the figures and figure legends are
presented as Runx1Re/Δ for brevity. Mice were bred and used in experiments
under UK Home Office regulations with approval of the University of
Edinburgh Ethical Review Committee.
Long-term repopulation assay
Cell suspensions from embryos at different stages were injected into irradiated
adult recipients (CD45.1/1) either directly (suspensions from AGM region or
E14.5 foetal livers) or after culture (E11.5 AGM region explants), along with
80,000 CD45.2/1 bone marrow carrier cells. Recipients were irradiated by a
split dose (600+550 rad with 3 h interval) of γ irradiation. Donor-derived
chimerismwasmonitored in blood at different time points after transplantation
using LSRFortessa (BD). The peripheral blood was collected by bleeding the
lateral tail vein into 500 µl of 5 mM EDTA/PBS, and erythrocytes were
depleted using PharM Lyse (BD). Cells were stained with anti-CD16/32
(Fc-block), CD45.1-APC (clone A20) and anti-CD45.2-PE (clone 104)
monoclonal antibodies (eBioscience).Appropriate isotype controlswere used.
Dead cells were excluded using 7AAD (eBioscience).
Flow cytometry analysis
Donor-derived contribution into different hematopoietic lineages in blood
or organs was determined by exclusion of recipient and carrier CD45.1+
cells and staining with lineage-specific monoclonal antibodies to Mac1,
CD3e, Gr1, B220 and Ter119 conjugated with PE, FITC, APC or biotin.
Biotinylated antibodies were detected by incubation with streptavidin APC
or PE (BD). All analyses were performed using FlowJo software (Tree Star).
Statistical analyses were performed in GraphPad Prism6 software.
AGM region explant culture
E11.5 AGM regions were dissected and cultured for 5 days on floating
0.8 µm Millipore membranes at the liquid-gas interface with IMDM+
Fig. 2. Development of haematopoietic cells in Runx1 knockout and
rescued embryos. (A) Representative plots of annexin V staining in CD41+
Ter119− cells in E10.5 AGM regions (7AAD+Ter119+CD41− cells were gated
out). (Top) The CD41lo population in Runx1LacZ/Δ embryos contains a smaller
proportion of annexin V+ cells than in heterozygous Runx1Δ/wt embryos (red
line separates CD41lo and CD41hi subsets); the same tendency but to a
smaller degree is observed in the CD41hi population. (Bottom) Proportion of
annexin V+ cells in CD41lo and CD41hi fractions in knockout Runx1LacZ/Δ and
control Runx1Δ/wt E10.5 AGM regions. Each circle represents an individual
embryo. Data were obtained from five independent experiments. (B) Active
caspase 3 expression in intra-aortic haematopoietic clusters in the wild-type
E11.5 AGM region (confocal microscopy). Dotted lines show the endothelial
lining of the dorsal aorta. D-V and A-P indicate the dorsoventral and
anterioposterior axes, respectively.
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media consisting of 20% FCS, L-Gln, P/S IMDM and growth factors
(100 ng/ml IL-3, 100 ng/ml SCF, and 100 ng/ml Flt3 ligand; all from
PeproTech) as previously described (Taoudi et al., 2008). After culture,
explants were dissociated enzymatically as previously described and
long-term repopulation assays were peformed.
Genotyping of embryos and assessment of Cre-mediated
recombination
Genotyping was performed by Southern blotting as described
previously (Liakhovitskaia et al., 2009). Specific recombination in
[CD41-Cre :: Runx1Δ/LacZ] embryos was always controlled by analysing
the recombination in blood and separately in the tail of the embryo.
Confocal microscopy
Whole-mount immunostaining was performed as previously described
(Yokomizo and Dzierzak, 2010). Briefly, embryos were dissected from the
yolk sac, fixed with 2% paraformaldehyde (PFA), dehydrated in ascending
concentration of methanol, and the head, limbs and one lateral body wall
removed. Samples were then rehydrated by 50% methanol, washed with PBS
and blocked in 50% FCS/0.5% Triton X-100. Embryos were incubated
overnight with primary antibodies: unconjugated rabbit anti-mouse active
caspase 3 (C92-605, BD Pharmingen, 1:100) and goat anti-mouse CD45
(AF114, R&D Systems, 1:100). Secondary antibodies used were anti-rabbit
NL557 (NL004, R&D Systems, 1:100) and anti-rat Alexa 488 (A-21208,
Invitrogen, 1:100). Then the embryos were washed, dehydrated in methanol
and cleared with BABB solution. Images were acquired using an inverted
confocal microscope (Leica SP8) and processed using Volocity software.
For immunostaining on sections, embryos were fixed in 4% PFA, washed
with PBS, incubated in 15% sucrose, embedded in OCT compound and
snap-frozen on dry-ice/ethanol. Frozen sections (10 µm) mounted on slides
were washed in 10% FCS/PBS (with penicillin/streptomycin), incubated in
PBS containing 10% FCS, penicillin/streptomycin and 0.05% Tween 20,
and peroxidase quenched with 3% hydrogen peroxide to be used with
Tyramide Amplification kit (Molecular Probes, #T30955). After applying
blocking buffer and washing in PBS, slides were incubated with anti-mouse
CD31 antibody (BD #553370, 1:30) for 1 h and washed with PBS. After
incubation with secondary Alexa Fluor 488 goat anti-rat antibody for 1-2 h
and washing with PBS, sections were blocked with PBS containing 10%
FCS, 0.05% Tween 20 and 5% normal rat serum. Endogenous avidin and
biotin were blocked for 30 min each (Abcam, #ab3387). Following 1 h
staining with biotinylated CD41 antibody (eBioscience, #13-0411-82,
1:100), sections were incubated with SAV-HRP and Tyramide Alexa Fluor
555 according to the Tyramide Amplification kit instructions. Sections were
mounted with HardSet Vectashield containing DAPI. Images were taken on
Zeiss 510 confocal microscope using the 63× oil objective and processed
with ZEN2011, Adobe Photoshop and Illustrator.
Fig. 3. HSCs are rescued in [CD41-Cre::
Runx1LacZ/Δ] embryos. (A) Experimental
design: left, transplantation of E14.5 foetal
livers; right, transplantation of fresh and
cultured E11.5 AGM regions. (B-D) Long-
term donor-derived haematopoietic
repopulation with (B) E14.5 foetal livers from
control Runx1wt/Δ and rescued Runx1Re/Δ
embryos; (C) uncultured E11.5 AGM region
cells; and (D) cultured E11.5 AGM region
cells. The donor cell contribution (%) into the
peripheral blood of recipient mice is shown
(for details of culture, transplantation and
analysis, see Materials and Methods). Each
symbol represents one recipient mouse.
Data obtained from three independent
experiments. (E) Representative examples
of long-term multilineage donor-derived
haematopoietic repopulation ([CD41-Cre::
Runx1LacZ/Δ] E14.5 foetal liver, 14 weeks
post-transplantation). Gating was carried out
on 7AAD-Ly5.2+ cells.
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RNA was islolated using the RNeasy mini kit (Qiagen) and treated with
DNase I (Ambion). DNA-free RNA (1 μg) was used as a template for the
random primed reverse transcription reaction using the Retroscript first-
strand synthesis kit for RT-PCR (Ambion). Ten percent of the RT reaction
were used for PCR with CD41 (5′-GTTTGGGAAGAAGGAAGATGGC-
3′ and 5′-ATTTCCACCGCTCCCAAGG-3′), CD45 (5′-GGCAAACACC-
TACACCCAGTGA-3′ and 5′-CCATGGGGTTTAGATGCAG-3′) and
actin (5′-CCAGAGCAAGAGAGGTATC-3′ and 5′-TGGAAGGTGGAC-
AGTGAG-3′) primers.
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